Category: Peptides Research
Research articles and educational content on peptides and longevity compounds, authored and reviewed by Dr. James, a board-certified neurosurgeon trained at Yale University, and Dr. Tom, a licensed pharmacist. All content is for research and educational purposes only.
-
IGF-1 LR3 Research: Understanding the Long-Arginine-3 Growth Factor Analog
Some peptides make you reconsider how growth works at the fundamental cellular level. IGF-1 LR3 is one of them. I first encountered it in the context of tissue repair research — specifically, why some tissues regenerate robustly after injury while others seem to plateau. The answer, in many cases, traces back to insulin-like growth factor…
-
Sermorelin Research: What the Science Reveals About This GHRH Analog
The first time I reviewed a patient’s IGF-1 panel and saw those numbers bottom out in a 45-year-old, I started asking different questions. Not just about hormone replacement, but about the upstream signals — the releasing hormones, the pulsatile rhythms, the hypothalamic-pituitary axis that orchestrates so much of how the body ages. That’s where Sermorelin…
-
Thymalin Research: What Scientists Are Discovering About This Thymic Peptide
There’s a moment in every researcher’s journey when a compound stops being just a name in a paper and starts feeling genuinely important. Thymalin had that effect on me. As someone who spent years in the operating room dealing with the consequences of immune dysregulation — post-surgical infections, delayed healing, the slow deterioration of aging…
-
Selank Research: What Scientists Are Learning About This Anxiolytic Neuropeptide
There’s a specific kind of research that catches my attention — compounds that seem to modulate the nervous system without the blunt force of traditional pharmacology. Selank is one of those. When I first came across the literature on this heptapeptide, I was struck by how precisely it seemed to target anxiety-related pathways without the…
-
Epithalon Research: What Scientists Are Discovering About This Telomere-Activating Peptide
If there’s one question that has quietly defined the outer edge of longevity science over the past thirty years, it’s this: can we do anything about telomeres? As a neurosurgeon who spends a significant amount of time in the aging biology literature, I’ve watched the telomere story evolve from theoretical curiosity to active research frontier…
-
Ipamorelin Research: What Scientists Are Discovering About This Selective Growth Hormone Secretagogue
There’s a moment in research when a compound stops being just another sequence of amino acids and starts looking genuinely interesting. For me, that moment with ipamorelin came when I read how selectively it stimulates growth hormone release — without the hormonal side effects that plagued earlier GH secretagogues. As a neurosurgeon who tracks peptide…
-
GHK-Cu Research: What Scientists Are Discovering About This Copper Peptide
There’s a molecule that’s been quietly accumulating one of the most compelling research profiles in all of peptide science — and most people have never heard of it. I came across GHK-Cu years ago while reviewing literature on wound healing and nerve regeneration, and honestly, the more I dug in, the more surprised I was…
-
MOTS-c Research: The Mitochondrial Peptide That’s Changing How Scientists Think About Aging
MOTS-c is the first peptide encoded in mitochondrial DNA — a discovery that changed how scientists understand cellular aging, energy metabolism, and the biology of exercise. Full research breakdown.
-
Tesamorelin Research: Growth Hormone Release, Mechanisms, and What the Studies Show
Tesamorelin is an FDA-approved GHRH analog with extensive human clinical data. Full breakdown of the GH-IGF-1 axis, visceral fat reduction trials, cognitive research, and comparison with ipamorelin.
-
Thymosin Alpha-1 Research: Immune Modulation, Mechanisms, and What the Science Shows
Thymosin Alpha-1 has decades of clinical data across hepatitis, cancer immunotherapy, and immune deficiency research. Full breakdown of T-cell modulation mechanisms, TLR9 agonism, hepatitis trial data, and COVID-19 research.
